Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,760.00    -14.00 (-0.79%)
Bid:
1,745.00
Ask:
1,748.00
Spread: 3.00 (0.172%)
Market Cap: £3.46b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Year End Trading Update

28 Aug 2025 07:00

RNS Number : 9365W
Softcat PLC
28 August 2025
 

28 August 2025

Softcat plc

Year End Trading Update

 

Softcat plc ("Softcat", or the "Group"), a leading UK provider of IT infrastructure technology and services, today publishes a trading update (unaudited) for the financial year ended 31 July 2025.

 

Following the update provided on 28 May, the Group continued to trade well during the fourth quarter, supported by further conversion of larger solutions projects. As a result, the Board now expects to deliver high-teens growth in full year gross profit and mid-teens growth in operating profit1. The Group also remains highly cash generative, with FY2025 cash conversion2 expected to be towards the top end of our guided range of 85%-95%.

 

Looking ahead, Softcat remains well positioned to deliver further growth. Excluding the significant incremental contribution from large projects in FY2025, the Board expects to deliver low double-digit gross profit growth and high single-digit operating profit growth in FY20263. Including the significant incremental contribution from large deals in the comparative period, this translates to reported rates of high single-digit gross profit growth and low single-digit growth in operating profit.

 

Softcat's FY2025 preliminary results are scheduled for release on 22 October 2025.

 

 

1 Full year operating profit adjusted to remove non-underlying items, including acquisition-related expenses such as the fair value of deferred contingent consideration, and implementation costs of the new sales system. FY2025 guidance remains on a consistent basis with that provided in previous statements.

2 Cash conversion adjusted to remove the impact of non-underlying items and acquisition-related cash flows.

3Operating profit excluding the significant incremental contribution from large deals in FY2025 is c.£170m.

 

For further information, please contact:

Softcat plc

Graham Charlton, Chief Executive Officer + 44 (0)1628 403 610

Katy Mecklenburgh, Chief Financial Officer

Michael Watts, Head of Investor Relations

 

Media Enquiries ‐ FTI Consulting LLP

Ed Bridges/Matt Dixon + 44 (0)20 3727 1000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLRTSIDFIE
Date   Source Headline
9th Jan 20243:48 pmRNSDirector/PDMR Shareholding
9th Jan 202412:42 pmRNSHolding(s) in Company
2nd Jan 20249:50 amRNSTotal Voting Rights
18th Dec 20239:58 amRNSBlock listing Interim Review
14th Dec 202311:29 amRNSDirector/PDMR Shareholding
14th Dec 202311:25 amRNSResult of AGM
12th Dec 20234:20 pmRNSDirector/PDMR Shareholding
8th Dec 20231:02 pmRNSDirector/PDMR Shareholding
1st Dec 20233:58 pmRNSTotal Voting Rights
28th Nov 20237:00 amRNSQ1 2024 Trading Update
24th Nov 20234:54 pmRNSDirector/PDMR Shareholding
24th Nov 20234:51 pmRNSDirector/PDMR Shareholding
8th Nov 20233:22 pmRNSDirector/PDMR Shareholding
1st Nov 202310:08 amRNSAnnual Financial Report and Notice of AGM
24th Oct 20237:00 amRNSFinal Results
10th Oct 202310:40 amRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNSNotice of Results
2nd Oct 202310:38 amRNSTotal Voting Rights
8th Sep 20232:32 pmRNSDirector/PDMR Shareholding
1st Sep 202310:04 amRNSTotal Voting Rights
10th Aug 202310:59 amRNSDirector/PDMR Shareholding
1st Aug 202312:22 pmRNSTotal Voting Rights
1st Aug 20237:00 amRNSAppointment of Non-Executive Directors
10th Jul 20232:10 pmRNSDirector/PDMR Shareholding
3rd Jul 20239:19 amRNSTotal Voting Rights
8th Jun 202311:23 amRNSDirector/PDMR Shareholding
1st Jun 202312:32 pmRNSTotal Voting Rights
1st Jun 202311:08 amRNSBlock listing Interim Review
30th May 20237:00 amRNSQ3 2023 Trading Update
25th May 20238:47 amRNSDirector Declaration
10th May 20238:59 amRNSDirector/PDMR Shareholding
2nd May 20235:08 pmRNSTotal Voting Rights
12th Apr 202310:14 amRNSDirector/PDMR Shareholding
3rd Apr 20239:34 amRNSTotal Voting Rights
28th Mar 20237:00 amRNSHalf-year Report
16th Mar 20232:39 pmRNSConfirmation of CFO Appointment Date
15th Mar 20237:00 amRNSNotice of Results
9th Mar 20232:27 pmRNSDirector/PDMR Shareholding
1st Mar 202312:27 pmRNSTotal Voting Rights
8th Feb 20231:05 pmRNSDirector/PDMR Shareholding
1st Feb 202312:41 pmRNSTotal Voting Rights
17th Jan 20237:05 amRNSDirectorate Change
10th Jan 20232:23 pmRNSDirector/PDMR Shareholding
3rd Jan 202311:34 amRNSTotal Voting Rights
3rd Jan 202311:31 amRNSDirector/PDMR Shareholding
22nd Dec 20223:00 pmRNSDirector/PDMR Shareholding
14th Dec 202210:12 amRNSResult of AGM
8th Dec 202212:29 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:57 pmRNSDirector/PDMR Shareholding
2nd Dec 202212:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.